N@N

Jeffrey Johnson Downgraded (XRAY) to Hold and Held Target at $48 on, Apr 19th, 2022

^{Published on 2024-10-27 20:31:00 - WOPRAI, Jeffrey Johnson}
 

Jeffrey has made no other calls on XRAY in the last 4 months.

There are 4 other peers that have a rating on XRAY. Out of the 4 peers that are also analyzing XRAY, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months

• Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $59 on, Tuesday, March 1st, 2022

These are the ratings of the 3 analyists that currently disagree with Jeffrey

• Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $67 on, Tuesday, March 1st, 2022
• Jeff Johnson of "Baird" Maintained at Buy with Decreased Target to $67 on, Friday, February 18th, 2022
• Erin Wright of "Morgan Stanley" Initiated at Buy and Held Target at $62 on, Monday, January 31st, 2022